Cancer Family
Connective and Soft Tissue Neoplasm
CI-CAN-00000010Explore in graph →
Non-malignant851 active trials17 approved drugs339 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000010Explore in graph →
Clinical trials
3,880 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05093751 | Automated Segmentation and Volumetry for Meningioma Using Deep Learning | completed | — | 600 | Seoul National University HospitalOTHER | 0 | Oct 26, 2021 | clinicaltrials |
| NCT05080868 | Infantile Hemangioma With Minimal or Arrested Growth : Epidemiology, Clinical Characteristics and Evolution | completed | — | 224 | Central Hospital, Nancy, FranceOTHER | 1 | Oct 18, 2021 |
| NCT04225494 | Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas(RAF) | completed | — | 52 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04672421 | The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study) | completed | N/A | 107 | Shin Poong Pharmaceutical Co. Ltd.INDUSTRY | 1 | Sep 29, 2021 | clinicaltrials |
| NCT02261207 | Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor | completed | Phase 2 | 17 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT01532687 | Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma | completed | Phase 2 | 54 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT03056599 | Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma | completed | Phase 1 | 23 | Presage BiosciencesINDUSTRY | 1 | Sep 24, 2021 | clinicaltrials |
| NCT04819633 | Evaluating Serum Sestrin in Leiomyoma Patients | completed | — | 61 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT05044624 | Retroperıtoneal Soft-Tıssue Sarcomas | completed | N/A | 18 | Istanbul Medeniyet UniversityOTHER | 0 | Sep 16, 2021 | clinicaltrials |
| NCT01913652 | Ph II Cabazitaxel DD Liposarcoma | completed | Phase 2 | 42 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 14, 2021 | clinicaltrials |
| NCT03525834 | Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 9, 2021 | clinicaltrials |
| NCT02471716 | Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor(FPA008-002) | completed | Phase 1 / Phase 2 | 66 | Five Prime Therapeutics, Inc.INDUSTRY | 6 | Aug 31, 2021 | clinicaltrials |
| NCT03521531 | Burden and Medical Care of Sarcoma in Germany(PROSa) | completed | — | 1,309 | Technische Universität DresdenOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT01010308 | Nadolol for Proliferating Infantile Hemangiomas | completed | Phase 2 | 20 | The Hospital for Sick ChildrenOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT00369564 | Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer | completed | Phase 3 | 250 | University of South FloridaOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT04388371 | Glutamine PET Imaging in LAM | completed | Phase 1 | 5 | Vanderbilt University Medical CenterOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT03768076 | an Istitution Experience on Parosteal OsTeosarcoma | completed | — | 220 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT04383288 | ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities | completed | — | 115 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT00366509 | Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases | completed | — | 157 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Aug 2, 2021 | clinicaltrials |
| NCT04983719 | Transcervical Myoma Biopsy Video(TMBV) | completed | — | 1 | University Hospital, MontpellierOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT02544711 | Cost-effectiveness Evaluation of the Use of a Patient Specific Instrument for Surgical Resection of Malignant Bone Tumor Within the Pelvis Versus the Conventional Surgical Treatment(MARGIC) | completed | N/A | 88 | Nantes University HospitalOTHER | 1 | Jul 28, 2021 | clinicaltrials |
| NCT02897128 | Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma | completed | — | 39 | The Cleveland ClinicOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04660591 | Length of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic Lesion | completed | N/A | 24 | Ain Shams UniversityOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT00731341 | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata | completed | N/A | 3 | Boston Scientific CorporationINDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT02216578 | Ph II CABOGIST in GIST | completed | Phase 2 | 51 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 15, 2021 | clinicaltrials |
| NCT01441635 | Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids | completed | Phase 2 | 271 | AbbVie (prior sponsor, Abbott)INDUSTRY | 0 | Jul 13, 2021 | clinicaltrials |
| NCT02925494 | An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 433 | AbbVieINDUSTRY | 3 | Jul 13, 2021 | clinicaltrials |
| NCT04955522 | Multimodal Imaging Analysis of Spinal Tumors | completed | — | 242 | Peking University Third HospitalOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT04955535 | Screening of Specific Genes for Pigmented Villous Nodular Synovitis | completed | — | 60 | Peking University Third HospitalOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT02181829 | Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases | completed | Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT01275222 | Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors | completed | Phase 1 / Phase 2 | 117 | Novartis PharmaceuticalsINDUSTRY | 4 | Jun 25, 2021 | clinicaltrials |
| NCT02164240 | Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST(SURE) | completed | Phase 1 | 14 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT03070899 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 1) | completed | Phase 3 | 526 | ObsEva SAINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT02888665 | Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 37 | Fred Hutchinson Cancer CenterOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT04736095 | 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas | completed | — | 50 | Aljazeera HospitalOTHER | 1 | May 25, 2021 | clinicaltrials |
| NCT01210209 | Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives(GENEWING) | completed | — | 350 | Institut CurieOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT04074291 | Cross Cultural Validation of the Italian Version of the Bt-DUX | completed | — | 51 | Istituto Ortopedico RizzoliOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT04002817 | Giant Cell Tumor of the Bone in Young Patients | completed | — | 18 | Istituto Ortopedico RizzoliOTHER | 1 | May 4, 2021 | clinicaltrials |
| NCT03158103 | A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | completed | Phase 1 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT02398058 | Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)(TOMAS) | completed | Phase 1 | 50 | Italian Sarcoma GroupNETWORK | 1 | Apr 14, 2021 | clinicaltrials |
| NCT02379845 | NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall | completed | Phase 2 / Phase 3 | 180 | NanobiotixINDUSTRY | 13 | Apr 6, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT03076333 | PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas | completed | N/A | 3 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 26, 2021 | clinicaltrials |
| NCT01967823 | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2021 | clinicaltrials |
| NCT00423618 | Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma(VORTEX) | completed | Phase 3 | 216 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT01140737 | A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas(Axi-STS) | completed | Phase 2 | 145 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT00841152 | Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute(BAGvsTCP) | completed | — | 120 | Turku University HospitalOTHER_GOV | 1 | Mar 16, 2021 | clinicaltrials |
| NCT04798326 | Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults(MW032) | completed | Phase 1 | 120 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Mar 15, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Oct 26, 2021source: clinicaltrials